MUC1 and idiopathic pulmonary fibrosis: In multivariable logistic regression analysis, KL-6 was not a statistically significant predictor of disease progression.<h4>Conclusions</h4>In our study, regardless of dose, consistent pirfenidone use for 12 months resulted in similar efficacy for the prevention of disease progression in patients with IPF.